Home license
 

Keywords :   


Tag: license

UCC Provisions for Royalties and License Fees

2016-04-28 01:06:44| Expeditors Newsflash - Europe-Africa Edition

Expeditors Newsflash - Europe - MAIR Edition

Tags: license fees provisions ucc

 

UCC Provisions for Royalties and License Fees

2016-04-27 10:00:00| Expeditors Newsflash - Americas Edition

Expeditors Newsflash - Americas Edition

Tags: license fees provisions ucc

 
 

Optodot and LG Chem sign patent license agreement for boehmite ceramic-coated separators for Li-ion batteries

2016-04-19 10:56:13| Green Car Congress

Tags: sign agreement license patent

 

BASF Obtains Battery Material License from CAMX Power LLC

2016-04-18 07:00:00| Coatings World Breaking News

Tags: power material license llc

 

FDA Accepts Supplemental Biologics License Application (sBLA) for KEYTRUDA (pembrolizumab) in Recurrent or Metastatic Head and Neck Cancer, and Grants Priority Review

2016-04-13 13:00:00| Merck.com - Product News

Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) for KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, for the treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) with disease progression on or after platinum-containing chemotherapy. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558An Phan, 908-255-6325orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: review application head license

 

Sites : [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] next »